top of page
A framework to support new product introduction in national health systems
Resource Library


The Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study
The Transitioning children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study was conducted in Benin, Nigeria, and Uganda....
May 4, 2023
269


GAP-f pDTG Implementation Considerations for National Programmes
In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 ...
May 24, 2022
375


Adult DRV/r (400/50mg) FAQs for Communities and PLHIV
CHAI developed these frequently asked questions (FAQs) to lay out information for communities and PLHIV on the subject of DRV/r (400/50...
Apr 13, 2022
231


Customizable Adult DRV/r (400/50mg) Healthcare Worker Training Slides
CHAI has developed a generic training curriculum that is intended to be adapted for local contexts and their respective training plans.
Mar 22, 2022
139


Adult DRV/r (400/50mg) Clinical Action Memo
Darunavir (DRV) is a best-in-class protease inhibitor (PI) used in combination with other antiretroviral (ARV) drugs for the...
Mar 17, 2022
326


Customizable Adult DRV/r (400/50mg) Prescribing Algorithm
CHAI is pleased to share a customizable guide to assist healthcare workers with prescribing and dispensing second-line (2L) DRV/r...
Mar 17, 2022
119


CHAI DRV/r 2L Product Profile
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
Mar 17, 2022
178


DRV/r (400/50mg) FAQs
CHAI developed these frequently asked questions (FAQs) to lay out information for national HIV programs considering the adoption and...
Mar 17, 2022
91


Pediatric DTG Healthcare Worker Resources
CHAI has developed new resources to support healthcare worker decision-making and counselling around pDTG. pDTG HCW Worker Overview Video...
Oct 18, 2021
211


Pediatric DTG Implementation Memo (English, French)
CHAI has developed this memo to lay out information for national HIV programs considering the introduction of pediatric...
Oct 11, 2021
96


Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children
This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal...
Jul 20, 2021
27


Community Resources for Pediatric DTG Scale-Up
Optimal and FASTER CAB members, with technical support from CHAI, developed a multi-media package of treatment literacy and advocacy...
Jul 9, 2021
58


2021 WHO Optimal Formulary and Limited-Use List for ARVs for Children
This sixth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended ART regimens for...
Apr 26, 2021
8


Pediatric DTG Clinical Studies Repository
A CHAI-curated repository of clinical studies in the development and implementation of pediatric DTG.
Mar 15, 2021
14
bottom of page